Literature DB >> 4621498

Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins.

T Uchida, A M Pappenheimer, A A Harper.   

Abstract

The isolation of a new type of mutant Corynephage beta, which carries a missense mutation in the structural gene for diphtheria toxin synthesis is described. The lysogenic C7(8)(beta(197))(tox-crm+) strain of Corynebacterium diphtheriae produces a nontoxic, extracellular protein of molecular weight 62,000. This protein is immunologically indistinguishable from toxin itself but inhibits the action of toxin on HeLa cells, probably by competing for attachment sites on the cell membrane. In contrast to fragment A derived from diphtheria toxin, fragment A(197) is unable to catalyze the inactivation of eucaryotic polypeptidyl-transfer RNA-transferase II. When mixtures of the two nontoxic mutant proteins, enzymically active crm(45) protein and enzymically inactive crm(197) protein, are subjected to mild treatment with trypsin in the presence of a thiol and then allowed to reoxidize after dialysis to remove excess thiol, "diphtheria toxin" is reconstituted in high yield.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621498     DOI: 10.1126/science.175.4024.901

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

1.  B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.

Authors:  T L McCool; C V Harding; N S Greenspan; J R Schreiber
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.

Authors:  R S Chu; T McCool; N S Greenspan; J R Schreiber; C V Harding
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Association between diphtheria toxin A- and B-fragment and their fusion proteins.

Authors:  H Stenmark; B N Afanasiev; S Ariansen; S Olsnes
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

Review 4.  Diphtheria toxin: mode of action and structure.

Authors:  R J Collier
Journal:  Bacteriol Rev       Date:  1975-03

Review 5.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

6.  Experimental diphtheritic neuropathy in the mouse: a study in cellular resistance.

Authors:  R Mellick; L Dolan; A D Kidman
Journal:  Br J Exp Pathol       Date:  1975-10

7.  Endosome fusion induced by diphtheria toxin translocation domain.

Authors:  Antonella Antignani; Richard J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-06       Impact factor: 11.205

8.  Uptake of diphtheria toxin and its fragment A moiety by mammalian cells in culture.

Authors:  C B Saelinger; P F Bonventre; B Ivins; D Straus
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.

Authors:  Alyson J Smith; Yufeng Li; Hélène G Bazin; Julien R St-Jean; Daniel Larocque; Jay T Evans; Jory R Baldridge
Journal:  Vaccine       Date:  2016-07-09       Impact factor: 3.641

10.  Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197.

Authors:  Enrico Malito; Badry Bursulaya; Connie Chen; Paola Lo Surdo; Monica Picchianti; Enrico Balducci; Marco Biancucci; Ansgar Brock; Francesco Berti; Matthew James Bottomley; Mikkel Nissum; Paolo Costantino; Rino Rappuoli; Glen Spraggon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.